Cargando…
Optogenetics-induced activation of glutamate receptors improves memory function in mice with Alzheimer’s disease
Optogenetics is a combination of optics and genetics technology that can be used to activate or inhibit specific cells in tissues. It has been used to treat Parkinson’s disease, epilepsy and neurological diseases, but rarely Alzheimer’s disease. Adeno-associated virus carrying the CaMK promoter driv...
Autores principales: | Wang, Ke-Wei, Ye, Xiao-Lin, Huang, Ting, Yang, Xi-Fei, Zou, Liang-Yu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6788230/ https://www.ncbi.nlm.nih.gov/pubmed/31397354 http://dx.doi.org/10.4103/1673-5374.262593 |
Ejemplares similares
-
Optogenetic gamma stimulation rescues memory impairments in an Alzheimer’s disease mouse model
por: Etter, Guillaume, et al.
Publicado: (2019) -
Optogenetic stimulation of Kiss1(ARC) terminals in the AVPV induces surge-like luteinizing hormone secretion via glutamate release in mice
por: Shen, Xi, et al.
Publicado: (2022) -
Neuroprotective Effect of Optogenetics Varies With Distance From Channelrhodopsin-2 Expression in an Amyloid-β-Injected Mouse Model of Alzheimer’s Disease
por: Cui, Xiaorui, et al.
Publicado: (2020) -
Optogenetics in Alzheimer’s Disease: Focus on Astrocytes
por: Mitroshina, Elena, et al.
Publicado: (2023) -
Multimodal neural probes for combined optogenetics and electrophysiology
por: Tian, Huihui, et al.
Publicado: (2021)